A 5-Part CME/CE Interview-Style Podcast Series Chaired by Sidney S. Braman, MD
Complete the pre-quiz poll to access the course episodes.
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Sidney S. Braman, MD | Nothing to disclose |
| Charles L. Daley, MD | Consultant/Advisor: AN2 Therapeutics; Genentech, Inc.; Insmed; Matinas BioPharma Holdings, Inc.; Paratek Pharma; Pfizer Inc.; Spero Therapeutics; Grant/Research Support: AN2 Therapeutics; Bugworks; Eli Lilly and Company; Insmed; Otsuka America Pharmaceutical, Inc; Paratek Pharma |
| Anne E. O’Donnell, MD | Consultant/Advisor: Boehringer Ingelheim; Electromed, Inc.; Insmed; Paratek Pharma; ZAMBON COMPANY S.P.A. Grant/Research Support: Boehringer Ingelheim; Insmed; Paratek Pharma; RedHill Biopharma Ltd.; ZAMBON COMPANY S.P.A. |
| Kevin Winthrop, MD, MPH | Consultant/Advisor: AN2 Therapeutics; Insmed; Paratek Pharma; RedHill Biopharma Ltd.; Renovion, Inc.; Spero Therapeutics; Vast Therapeutics Grant/Research Support: Insmed; Paratek Pharma; RedHill Biopharma Ltd.; Spero Therapeutics; Vast Therapeutics |
